<code id='32C152ADA3'></code><style id='32C152ADA3'></style>
    • <acronym id='32C152ADA3'></acronym>
      <center id='32C152ADA3'><center id='32C152ADA3'><tfoot id='32C152ADA3'></tfoot></center><abbr id='32C152ADA3'><dir id='32C152ADA3'><tfoot id='32C152ADA3'></tfoot><noframes id='32C152ADA3'>

    • <optgroup id='32C152ADA3'><strike id='32C152ADA3'><sup id='32C152ADA3'></sup></strike><code id='32C152ADA3'></code></optgroup>
        1. <b id='32C152ADA3'><label id='32C152ADA3'><select id='32C152ADA3'><dt id='32C152ADA3'><span id='32C152ADA3'></span></dt></select></label></b><u id='32C152ADA3'></u>
          <i id='32C152ADA3'><strike id='32C152ADA3'><tt id='32C152ADA3'><pre id='32C152ADA3'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:91427
          virtual appointment
          Adobe

          You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how tech is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. 

          FDA approves device to save limbs of vascular disease patients

          advertisement

          An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot that wouldn’t heal.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Why scientists need input from humanists on sensitive research
          Why scientists need input from humanists on sensitive research

          AdobeScientistsaretaughtearlyinourtrainingthatcriticismisafundamentalpartofthejob.Whatwearenotusuall

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

          ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas